Thanks to you, treatments that are as effective as chemotherapy are now available for men to take at home.
New data shows more men are getting access to the best scans for diagnosis, but there's more work to do.
New data shows prostate cancer is the most common cancer in the UK. Here's why it's not all bad news, and what we do next.
Our response to new data showing prostate cancer deaths hit a record high of 12,000 in one year.
The Government's spending review included the promise of funding to train Clinical Nurse Specialists, but more action is needed to address a massively strained workforce.
Allowing men to access test results online provides just as good support while saving the NHS money.
We publish new best practice guidelines on active surveillance, as NICE advise it should be offered to men with low risk localised prostate cancer.
After years of us campaigning, Northern Ireland's Department of Health says it will now develop a strategy for the only Home Nation without one – and we're making sure prostate cancer is a key part of it.
BLOG: This week, the Government unveiled its new 10-year plan for the NHS in England. We scrutinised all 136 pages of it to find out what impacts it could have for men being treated or diagnosed for prostate cancer, and how it could help – or hinder – our own plans.
The National Institute for Health and Care Excellence has recommended pre-biopsy mpMRI scans and a host of other improvements to diagnosis and treatments for prostate cancer become standard NHS practice across the UK. While we back the proposals, we're calling for enough scanners and trained staff to deliver them.